📅 May 3, 2026 | 👤 Restorative and Medical Skincare Researcher Simon Finch | ⏱ 16 min read

PDRN and the Skin Microbiome: How Nucleotide Repair Affects the Bacterial Ecosystem of Aging Skin

If you are a woman over 60 wondering whether your skincare routine addresses the root cause of aging skin rather than just the surface signs, the answer is almost certainly no — unless you have heard of PDRN. Polydeoxyribonucleotide, a DNA-derived regenerative compound originally developed for wound healing, is now emerging as one of the most scientifically compelling ingredients in restorative dermatology. But its most radical insight is this: to repair aging skin, you must first understand how DNA damage reshapes the microscopic ecosystem living on your skin.

This article explores the two-way relationship between nucleotide repair and the skin microbiome in women 60+. We will examine how PDRN works at the molecular level, how aging disrupts the bacterial communities that protect your skin, and why combining nucleotide restoration with microbiome support may be the most effective anti-aging strategy currently available.

The Skin Microbiome After 60: A Story of Loss and Chaos

The skin microbiome — the collection of bacteria, fungi, and viruses living on your skin — is not static. It changes across the lifespan, and the most dramatic shifts occur after menopause and into the seventh decade of life.^[1] Understanding these changes is essential because the microbiome is not a passive passenger; it actively regulates inflammation, barrier function, and immune defense.

What Happens to the Bacterial Ecosystem

In healthy young skin, the dominant bacterial genus is Cutibacterium (formerly Propionibacterium), which thrives in sebaceous environments and helps maintain acidic pH. After age 60, several well-documented shifts occur:

• Decline in Cutibacterium species — Sebum production drops by roughly 60% after menopause, reducing the habitat for these beneficial organisms.^[2]
• Increase in Corynebacterium and Acinetobacter — These genera become more abundant on aged skin, and their metabolic byproducts can contribute to inflammation and odor.^[2]
• Loss of overall microbial diversity — While absolute alpha diversity (the number of different species) may increase, the stability and functional robustness of the community decline, making the skin more vulnerable to pathogen colonization.^[3]
• Increased pH — The skin surface pH rises from approximately 5.0 to 6.0–6.5 after menopause, shifting the competitive balance away from acid-loving commensals toward opportunistic species.^[2]

PDRN Mechanism: How Nucleotides Talk to Skin Cells

PDRN is a mixture of deoxyribonucleotide fragments, typically derived from salmon or trout sperm DNA (and increasingly from microbial sources), with molecular weights ranging from 50 to 1,500 kDa.^[4] Its activity is mediated through two convergent pathways: adenosine A2A receptor activation and the DNA salvage pathway.

The Adenosine A2A Receptor Pathway

PDRN binds to adenosine A2A receptors expressed on fibroblasts, keratinocytes, and endothelial cells. This binding triggers a cascade of downstream effects:

• Increased VEGF and FGF expression — Promoting angiogenesis and improving nutrient and oxygen delivery to skin cells.^[4]
• Reduction of pro-inflammatory cytokines — PDRN suppresses TNF-α, IL-6, and IL-1β while promoting anti-inflammatory mediators, shifting the skin from a chronic inflammatory state toward a regenerative one.^[5]
• Stimulation of fibroblast proliferation — Leading to increased collagen and elastin synthesis, restoring dermal matrix density that declines by approximately 1% per year after menopause.^[4]

The Salvage Pathway: Direct Nucleotide Provision

Beyond receptor signaling, PDRN offers a more direct contribution: it supplies the raw nucleotide building blocks that cells need for DNA repair via the "salvage pathway."^[6] This is particularly relevant for aging skin, where endogenous nucleotide synthesis declines and DNA damage accumulates from years of UV exposure, oxidative stress, and replicative aging.

The Inflammaging Cycle: Where Microbiome and DNA Repair Converge

One of the most important concepts in geriatric dermatology is inflammaging — chronic, low-grade inflammation driven by the accumulation of cellular damage and dysregulated immune responses.^[3] This is where the microbiome and nucleotide repair intersect in a vicious cycle.

How the Cycle Works

1. DNA damage accumulates in skin cells and triggers the release of damage-associated molecular patterns (DAMPs) that activate inflammatory pathways.
2. Inflammation alters the microbial habitat — changes in pH, sebum composition, and immune surveillance create conditions favoring dysbiosis.
3. Dysbiosis amplifies inflammation — pathogenic bacteria produce metabolites (lipoteichoic acid, flagellin, porphyrins) that further activate toll-like receptors on keratinocytes, perpetuating the inflammatory signal.^[3]
4. Chronic inflammation impairs DNA repair — oxidative stress from inflammatory cells generates reactive oxygen species that cause further DNA damage, closing the loop.

PDRN's Role in Breaking the Cycle

PDRN interrupts this cycle at two critical points. First, by providing nucleotides for DNA repair, it reduces the DAMPs that initiate the inflammatory cascade. Second, by activating A2A receptors, it directly suppresses NF-κB signaling and reduces pro-inflammatory cytokine production.^[5] The result is a dampening of the inflammatory signal that drives dysbiosis, allowing the microbial community to re-establish a healthier equilibrium.

Barrier Integrity: The Physical Foundation of a Healthy Microbiome

The skin barrier and the microbiome exist in a symbiotic relationship. A healthy barrier provides the physical structure and chemical environment (pH, lipids, antimicrobial peptides) that supports commensal bacteria. In turn, commensal bacteria metabolize sebum into free fatty acids that maintain acidic pH and produce bacteriocins that inhibit pathogen colonization.^[2]

How PDRN Strengthens the Barrier

PDRN has been shown to improve multiple parameters of barrier function:

Each of these improvements creates a more favorable environment for beneficial bacteria. For example, reduced TEWL and increased ceramides support the growth of lipid-dependent bacteria like Cutibacterium acnes, while normalized antimicrobial peptide expression prevents the overgrowth of opportunistic pathogens.^[2]

Microbial-Derived PDRN: The Next Frontier

A groundbreaking 2025 study by Chae et al. reported the first successful extraction of PDRN from microbial sources — specifically Lactobacillus rhamnosus (L-PDRN).^[7] This development has profound implications for the microbiome-PDRN connection.

Why L-PDRN Matters for Aging Skin

The study found that L-PDRN consists of smaller DNA fragments (under 100 base pairs) compared to salmon-derived PDRN (200–800 base pairs), suggesting greater bioavailability and skin penetration.^[7] Equally important, L-PDRN demonstrated:

• 2× higher SOD-like antioxidant activity at 5,000 ppm compared to salmon-derived PDRN
• Superior wound-healing in HaCaT keratinocytes, even under TNF-α-induced inflammatory conditions
• Enhanced immunostimulatory effects under non-inflammatory conditions while maintaining anti-inflammatory effects under LPS stimulation — suggesting intelligent immune modulation rather than blanket suppression
• Alternative signaling engagement — L-PDRN activates p38 and ERK pathways beyond the traditional FAK/AKT route, offering functional versatility^[7]

Practical Protocol: Integrating PDRN into a Microbiome-Supporting Routine

For women 60+, the most effective approach combines PDRN's nucleotide repair with microbiome-supporting practices. Here is a science-backed protocol:

Step 1: Repair the Barrier First

PDRN serums or treatments should be applied to clean, slightly damp skin. The nucleotide fragments require an intact barrier to work optimally. For extremely compromised skin (TEWL >15 g/m²/h), a 2–4 week period of barrier repair (ceramides, niacinamide, gentle cleansing) before introducing PDRN may enhance results.

Step 2: Support the Microbiome

Post-PDRN application, allow 15–20 minutes for absorption before applying a microbiome-friendly moisturizer. Look for formulations containing prebiotic sugars (xylitol, fructooligosaccharides), postbiotic metabolites (lactic acid, butyrate), or gentle lipid ratios that mimic the skin's natural sebum profile. Avoid harsh preservatives (parabens in high concentrations, methylisothiazolinone) that can disrupt the nascent microbial community.

Step 3: Choose the Right PDRN Delivery

Topical PDRN serums (0.5–2% concentration) are now available from several Korean and European cosmeceutical brands. For more profound rejuvenation, mesotherapy or microneedling with PDRN (often referred to as "rejuran" or "PN" treatments) delivers the nucleotide fragments directly to the dermis, where fibroblasts and endothelial cells are most receptive. These in-office treatments may produce visible improvement within 4–6 weeks, with effects lasting 6–12 months.

Step 4: Protect the Investment

PDRN repairs damage; sunscreen prevents it. Broad-spectrum SPF 50+ (mineral or hybrid) is non-negotiable after PDRN treatment, as the newly stimulated cellular activity can increase photosensitivity transiently. Combine this with antioxidant support (vitamin C or ferulic acid in the morning) to reduce the oxidative burden on both skin cells and their microbial inhabitants.

What the Evidence Says: A Summary of Key Studies

Special Considerations for Women 60+

While PDRN's benefits are broadly applicable, several factors make it particularly valuable for women in this age group:

Hormonal Context

The dramatic drop in estrogen at menopause accelerates collagen loss (up to 30% in the first five years after menopause), reduces sebum production, and increases skin pH.^[2] PDRN's stimulation of fibroblast activity and collagen synthesis provides a non-hormonal pathway to counteract estrogen-dependent skin aging. For women who cannot or choose not to use hormone replacement therapy, PDRN offers a targeted alternative.

Cumulative UV Damage

By age 60, the average woman has accumulated decades of subclinical UV damage. PDRN has been shown to reduce cyclobutane pyrimidine dimers (CPDs) — the primary DNA lesion caused by UVB — when applied post-exposure, acting through the A2A receptor to enhance nucleotide excision repair (NER) activity.^[5]

Barrier Recovery

Aging skin takes significantly longer to recover from barrier disruption. PDRN accelerates re-epithelialization and restores lipid synthesis, reducing recovery time by approximately 40% in in-vitro models of aged keratinocytes.^[5]

Microbiome Vulnerability

Women over 60 are more susceptible to Staphylococcus aureus colonization and recurrent skin infections. By strengthening the barrier and reducing the inflammatory environment that favors pathogenic bacteria, PDRN indirectly supports the competitive advantage of commensal organisms.^[3]

Safety and Compatibility

PDRN is remarkably well-tolerated. The purification process (high-temperature extraction from salmonid sperm DNA) inactivates proteins and peptides, eliminating immunological concerns.^[4] In clinical studies spanning over two decades, no significant adverse events have been attributed to topical or injectable PDRN. For women 60+ who may have sensitive or reactive skin, this safety profile is a critical advantage.

PDRN is compatible with most active ingredients (retinoids, vitamin C, peptides, AHAs) but should not be applied simultaneously with strong acids or exfoliants, as these can denature the nucleotide fragments. A simple guideline: apply PDRN on clean skin, wait 15 minutes, then layer other actives.

Looking Forward: The Microbiome-Nucleotide Axis

The emergence of L-PDRN from Lactobacillus rhamnosus signals a broader shift in how we think about skincare ingredients. Rather than viewing the microbiome and cellular repair as separate domains, the most advanced formulations are beginning to treat them as an integrated system — the microbiome-nucleotide axis.

We are likely to see a new generation of "biosynthetic" PDRN produced through fermentation, similar to how hyaluronic acid is now produced through bacterial fermentation rather than animal extraction. This would offer not only sustainability advantages but also the ability to tune fragment size for specific skin depths and conditions. For women 60+, the ideal product may be a PDRN of precisely 80–120 base pairs (optimized for anti-aging, anti-inflammatory, and microbiome-compatible effects) delivered in a formulation that also contains prebiotic sugars and postbiotic lipids.